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Prior studies with transgenic zebrafish confirmed the functionality of the transcription factor Gal4 to drive expression of other genes under the
regulation of upstream activator sequences (UAS). However, widespread application of this powerful binary system has been limited, in part, by
relatively inefficient techniques for establishing transgenic zebrafish and by the inadequacy of Gal4 to effect high levels of expression from UAS-
regulated genes. We have used the Tol2 transposition system to distribute a self-reporting gene/enhancer trap vector efficiently throughout the
zebrafish genome. The vector uses the potent, hybrid transcription factor Gal4-VP16 to activate expression from a UAS:eGFP reporter cassette. In
a pilot screen, stable transgenic lines were established that express eGFP in reproducible patterns encompassing a wide variety of tissues,
including the brain, spinal cord, retina, notochord, cranial skeleton and muscle, and can transactivate other UAS-regulated genes. We demonstrate
the utility of this approach to track Gal4-VP16 expressing migratory cells in UAS:Kaede transgenic fish, and to induce tissue-specific cell death
using a bacterial nitroreductase gene under UAS control. The Tol2-mediated gene/enhancer trapping system together with UAS transgenic lines
provides valuable tools for regulated gene expression and for targeted labeling and ablation of specific cell types and tissues during early zebrafish
development.
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The ability to regulate gene expression along defined
temporal and spatial coordinates represents an invaluable tool
for investigating gene function in the developing embryo. In
Drosophila, spatially restricted transgene expression is fre-
quently accomplished using a bipartite Gal4/UAS system
(Duffy, 2002; Fischer et al., 1988). This system relies upon
tissue-specific expression of the yeast Gal4 transcriptional
activator to drive expression of transgenes placed under the⁎ Corresponding author. Fax: +1 410 502 2913.
E-mail address: mparson3@jhmi.edu (M.J. Parsons).
1 These authors contributed equally to this work.
2 The Halpern, Leach and Parsons Labs contributed equally to this work.
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.01.033regulation of multimerized Gal4-responsive upstream activator
sequences (UAS). Recent refinements have added the capacity
for temporal regulation, using either Gal4-steroid receptor
fusion proteins or a temperature-sensitive Gal4 antagonist
(McGuire et al., 2004). Reflecting the tremendous utility of
“Gal4 driver” lines, several large-scale screens have exploited
P-elements to distribute Gal4 insertions throughout the Droso-
phila genome, in the form of gene or enhancer traps (Brand and
Perrimon, 1993; Lukacsovich et al., 2001). Detailed descrip-
tions of 6966 separate Gal4 insertions are currently maintained
in the Drosophila Gal4 Enhancer Trap Insertion Database,
including information on insertion sites, expression patterns and
mutant phenotypes (http://flymap.lab.nig.ac.jp/~dclust/getdb.
html). In addition to enabling a wide variety of reverse genetic
applications, Gal4 driver lines have also been utilized for
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ted UAS elements are used to activate endogenous gene
expression in an appropriate Gal4 background (Rorth et al.,
1998).
In zebrafish, application of the Gal4/UAS system for
transgene expression under the control of identified promoters
was pioneered by Scheer and Campos-Ortega (1999). Although
they were able to show Gal4-mediated activation of 5xUAS
reporters in stable transgenics, levels of reporter expression
were low. Addressing this concern, Koster and Fraser (2001)
employed the Gal4-VP16 fusion protein comprised of the Gal4
DNA binding domain fused to the transcriptional activator
domain of the herpes simplex virus VP16 protein (Sadowski et
al., 1988). The Gal4-VP16 fusion protein generated robust
expression from a 14xUAS:eGFP reporter in transient activa-
tion assays in zebrafish embryos, although recovery of stable
transgenic lines was not reported.
In spite of these encouraging early efforts, the use of Gal4/
UAS technology has remained relatively limited, exemplified
by the fact that only four transgenic Gal4 driver lines are
currently registered by the Zebrafish Information Network
(www.zfin.org). The paucity of driver lines may reflect the
relative inefficiency of conventional methods for zebrafish
transgenesis. However, the development of more efficient
approaches, utilizing either retroviral vectors (Amsterdam et al.,
2004; Ellingsen et al., 2005) or transposable elements
(Davidson et al., 2003; Kawakami et al., 1998; Koga and
Hori, 2001) facilitates widespread application of Gal4/UAS
methodologies in the zebrafish.
The Tol2 transposable element from the Japanese medaka
fish, Oryzias latipes, has emerged as a particularly simple and
effective system to generate a high rate of stable transgenesis in
zebrafish (Kawakami, 2004). Tol2 is a member of the hAT
(hobo, Ac, Tam3) family of terminal inverted repeat-type
transposable elements (Kempken and Windhofer, 2001), a
group of autonomous transposons with internal sequences
encoding the transposase protein necessary for mobilization.
Derivatives of the Tol2 element lacking the transposase coding
sequence can be effectively mobilized by provision of
exogenous transposase activity. Transposase-deficient Tol2
vectors have been developed and in combination with
transposase mRNA provide highly efficient delivery of
transgenes to the zebrafish genome (Kawakami et al., 2000;
Urasaki et al., 2006). Rates of germline transmission as high as
30–50% permit Tol2 vectors to be utilized for genome-wide
distribution of gene and/or enhancer trap elements (Kawakami
et al., 2004; Parinov et al., 2004).
As a means to expand available Gal4/UAS capabilities in
zebrafish, we have used the Tol2 element to distribute a self-
reporting Gal4-VP16;UAS:eGFP gene/enhancer trap construct
throughout the zebrafish genome, and conducted a pilot screen
for lines displaying Gal4-VP16-dependent activation of the
UAS:eGFP reporter. This approach has allowed the recovery
of 15 stable transgenic lines displaying distinct temporally and
spatially restricted patterns of eGFP expression in a wide
variety of cell and tissue types. Most lines are capable of
transactivation, driving tissue-specific exogenous genes viaUAS regulation. Here, we demonstrate transactivation in UAS:
Kaede transgenic fish by photoconversion of Gal4-VP16
expressing cells, a labeling method used to trace migratory
cells during development. Transactivation in UAS:nfsB-
mCherry transgenic fish leads to production of a fusion
protein consisting of nitroreductase (NTR) (Drabek et al.,
1997; Pisharath et al., in press; Curado et al., in press) and the
fluorescent protein mCherry, enabling Gal4-VP16 expressing
cells to be monitored and selectively ablated.
Together these results extend the number of currently
available zebrafish Gal4-VP16 driver lines, and further support
the feasibility of conducting genome-wide screens to produce
large panels of zebrafish Gal4 driver lines, analogous to those
available in Drosophila.
Materials and methods
Gene/Enhancer trap vector design
The SAGVG (splice acceptor-Gal4-VP16;UAS:eGFP) vector is a Tol2
transposon-based, bipartite construct consisting of a Gal4-VP16 gene/enhancer
trap as well as a cis-linked UAS-regulated eGFP reporter (Fig. 1A). The vector
contains a splice acceptor sequence derived from the rabbit β-globin gene (275
base pairs of intron 2 and 45 base pairs of exon 3) which was amplified from the
pT2KXIGΔIN vector (Urasaki et al., 2006) and cloned upstream of tandem
Gal4-VP16 and UAS:eGFP elements (Koster and Fraser, 2001). The entire unit
was subcloned into the pT2KXIGΔIN vector to be flanked by a 535 base pair
(bp) right Tol2 arm and a 517 bp left Tol2 arm.
Generation of Tg(Gal4-VP16;UAS:eGFP) lines
One-cell stage embryos were injected through the chorion with 1 nl of a
solution containing plasmid DNA at a concentration of 12.5 ng/μl, along with
Tol2 transposase RNA at 12.5 ng/μl, KCl at 200 mM and phenol red at 0.05%
(Kawakami et al., 2004). Injected F0 embryos were raised and the resulting fish
interbred to produce F1 progeny. F1 embryos were examined on a fluorescent
stereomicrosope at 2 and 5 days post fertilization (dpf). Embryos and larvae
exhibiting tissue-restricted eGFP fluorescence were selected and raised. Among
49 pairs of F0 fish, 28 intercrosses generated F1 embryos with tissue-restricted
eGFP fluorescence. F1 adults were then outcrossed to wild-type AB fish, and F2
progeny were re-screened. Fifteen stable lines displaying spatially and
temporally restricted patterns of eGFP expression were recovered in the F3
generation. Transgenic fish lines are freely available upon request to
halpern@ciwemb.edu and will be deposited in ZIRC (http://zfin.org/zirc/
home/guide.php). Plasmid requests should be directed to mparson3@jhmi.edu.
Generation of the Tg(UAS:Kaede)s1999t transgenic line
The Kaede open reading frame (Ando et al., 2002) was kindly provided by
Atsushi Miyawaki. Flanking sequences were amplified by PCR and inserted
downstream of UAS and the E1b promoter in a 14xUAS:eGFP construct
(Koster and Fraser, 2001) using the Xi Clone PCR Cloning System (Gene
Therapy Systems, San Diego, CA). I-SceI meganuclease recognition sites were
inserted flanking the UAS:Kaede construct to increase the rate of transgenesis
and ensure single insertions (Thermes et al., 2002). Wild-type TL embryos
were injected at the 1–2 cell stage with a solution of 50 ng/μl UAS:Kaede
DNA and 5 U/μl I-SceI endonuclease in 0.04% Phenol Red. Injected F0
animals were raised to adulthood and interbred. F1 embryos were pooled and
screened by PCR for the presence of the UAS:Kaede transgene. F0 founder
animals giving rise to UAS:Kaede-positive offspring were then mated to
existing GAL4 driver lines to identify expressors. All transgenic F1 gave the
identical expression pattern, regardless of their founder parent. The stable Tg
(UAS:Kaede)s1999t line was then propagated by outcrossing a single F0 founder
male to wild-type TL fish.
Fig. 1. Tissue-specific eGFP expression in stable transgenic Gal4-VP16;UAS:eGFP lines. (A) Schematic depiction of SAGVG vector, containing sequence encoding
Gal4-VP16 fusion protein, preceded by splice acceptor (orange), and followed by Gal4-VP16-responsive eGFP reporter cassette consisting of Gal4-responsive
upstream activating sequence (UAS), adenoviral E1b minimal promoter element (E1b). The entire construct is flanked by right and left arms of Tol2 (yellow triangles).
(B) Line c218 with variable expression in somitic muscle fibers at 3 dpf. (C) Line c220 with expression in forebrain and retina at 2 dpf. (D) Line c223 with expression
in midbrain, hindbrain and ventral spinal cord at 5 dpf. (E) Line c229 with expression in the pineal (arrow) and early lens expression at 5 dpf. (F) Line c233 with
expression in ventral cells dorsal to cardinal vein at 5 dpf. (G) Line c247 with expression in the caudal notochord at 1.5 dpf. (H) Line c236 with expression in
subregions of the brain and in the heart at 6 dpf. (I) Line c237 with expression in putative sensory neurons anterior to the otocyst, subsets of spinal cord interneurons
and the ventral tail fin at 6 dpf. (J) Line c240 with expression throughout the skeletal and head musculature at 5 dpf. (K) Line c228 with expression in hindbrain
rhombomeres 5 and 6 at 1.5 dpf. (L) Line c223 with expression in retina, dorsal midbrain and hindbrain floor plate at 1.5 dpf. (M) Higher magnification of line c229
demonstrating selective labeling of the pineal at 5 dpf (earlier expression, not shown). (N) Labeling of cranial musculature in c240 at 5 dpf. (O) Higher magnification
image of c233 highlighting ventral cells shown in F. (P) c223 also exhibits labeling of the exocrine pancreas at 5 dpf (earlier expression, not shown). (Q) Higher
magnification of the heart labeling in line c236 at 6 dpf. High levels of eGFP are observed in heart valves (arrow and refer to supplemental movie). (R) Higher
magnification image of putative sensory neurons in line c237. (B–J) Lateral views of whole larvae. (K, L, O, Q and R) Lateral view with anterior to the left; (P) lateral
view with anterior to the right. (M) Dorsal and (N) ventral view. All larvae were imaged on a Leica MZFlII stereomicroscope.
813J.M. Davison et al. / Developmental Biology 304 (2007) 811–824Cloning of insertion alleles linked to eGFP expression
Linker-mediated PCR (LM-PCR) was utilized to clone genomic
sequences flanking vector insertion sites. Adult F1 or F2 fish were crossedto generate transgenic embryos which were sorted into eGFP-positive and
eGFP-negative groups. Genomic DNA was purified from pooled or individual
embryos according to previously published protocols (Parsons et al., 2002;
Wang et al., 1995). LM-PCR was performed according the protocol described
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digested with either NlaIII, BfaI or DpnII. Modified oligonuclotides were
annealed to generate linkers and ligated to digested DNA. NlaIII and BfaI
linker oligos were identical to those described by Dupuy; DpnII linker oligos
were as follows: 5′GTAATACGACTCACTATAGGGCTCCGCTTAAGG-
GAC3′ and (5′ PO4)-GATCGTCCCTTAAGCGGAG-(3′ C3 spacer).
The first round of the nested PCR was performed using linker primer 1 5′
GTAATACGACTCACTATAGGGC3′ with either Tol2 Left 1.1 5′TCAAGTA-
AAGTAAAAATCCCCAAAA3′ or Tol2 Right 1.3 5′TTGAGTAAAATT-
TTCCCTAAGTAC3′, under the following cycling conditions: 94 °C (15 s)–
51 °C (30 s)–68 °C (1 min), 25–30 cycles. Second round nested PCR was then
performed using linker primer 2 5′AGGGCTCCGCTTAAGGGAC3′with either
Tol2 Left 2.1 5′AAAATCCCCAAAAATAATACTTAAGTACAGTAA3′ or
Tol2 Right 2.1 5′TGTACTTTCACTTGAGTAAAATTTTTGAG3′ and the
following cycling conditions: 94 °C (15 s)–57.5 °C (30 s)–68 °C (1 min), 25–
30 cycles. The PCR products were resolved by electrophoresis on a 3% agarose
gel. Products selectively amplified in eGFP-positive embryos were cloned and
sequenced. Sequences flanking the Tol2 arms were used to search the Ensembl
Danio rerio genomic sequence database to position and orient the insert within
the zebrafish genome. To confirm the presence of a cloned insertion correlated
with eGFP reporter expression, PCR primers were designed based on flanking
sequence (see Supplementary Table 1).
Gal4-VP16-dependent activation of additional UAS-regulated
transgenes
To assess whether stable transgenic lines are capable of activating a
second UAS-regulated gene in trans, a UAS:mCherry plasmid construct
was synthesized by cloning an mCherry cDNA obtained from R. Tsien
(Shaner et al., 2004), downstream from the same 14× UAS, E1b minimalTable 1
Recovered lines and mapping of Gal4-VP16;UAS:eGFP inserts
Line Expression pattern Transactivation
c215 Cranial cluster, ear Cranial cluster, ear
c218 Skeletal muscle Skeletal muscle
c220 Retina, forebrain, hatching gland Retina, forebrain
c223 CNS, floor plate, pancreas CNS, floor plate
c228 Hindbrain (r5, r6) None
c229 Pineal, lens Pineal, lens
c230 Retina, midbrain, muscle,
notochord, hatching gland
Muscle, notochord,
hatching gland
c233 Uncharacterized ventral
cells in trunk
Uncharacterized ventra
cells in trunk
c235 Forebrain stripe Some forebrain neuron
c236 Heart, heart valve None
c237 Cranial ganglia, spinal cord, retina Cranial ganglia, spinal
cord, retina
c239 Yolk Yolk
c240 Somitic muscle, head musculature Somitic muscle,
head musculature
c241 Cranial cluster Cranial cluster
c247 Notochord Notochord
a These positions were assigned on the basis of cloned flanking sequence homolo
based on predicted flanking genomic sequence.promoter sequence used in the SAGVG vector. Gal4-VP16;UAS:eGFP
carriers were crossed to AB fish and resultant embryos were injected with
non-linearized UAS:mCherry plasmid DNA at a concentration of 150 ng/μl
and examined for transient red fluorescence 24–48 h later. To confirm that
candidate Gal4-VP16 driver lines can activate stably integrated UAS-
regulated transgenes, F2 adults were mated with UAS:Kaede transgenic fish.
Transgenic embryos were identified on the basis of their tissue-restricted
eGFP expression and subjected to green-to-red photoconversion by timed
exposure (from 15 to 60 s) to UV light using a DAPI filter (excitation
365 nM, emission 415 nM) under 10× or 20× objectives on a Zeiss
Axioskop microscope. Enhanced throughput filters (Chroma Technology
Corp.) were used to visualize eGFP/Kaede (ET-GFP #49002) or
photoconverted Kaede (ET-Cy3 #49004) and produced no overlap in
fluorescence. To track the fate of migratory cells in c233, only the most
caudal cells of 6 dpf larvae were photoconverted. Control and photo-
converted transgenic larvae were allowed to develop in the dark for 2 days
and then imaged again at 8 dpf.
Prodrug-dependent cell ablation in Tg(Gal4-VP16;UAS:eGFP) lines
The E. coli gene nfsB, which encodes nitroreductase B, was cloned in frame
to mCherry (Pisharath et al., in press). The nfsB-mCherry cassette was cloned
downstream of the 14× UAS, E1b minimal promoter sequence. The UAS:nfsB-
mCherry construct was cloned into the backbone of the T2KXIGΔIN vector to
flank the transgene with Tol2 arms. Transgenic fish were generated by Tol2-
mediated transgenesis and identified F0 Tg(UAS:nfsB-mCherry) carriers were
crossed to c223 and c230 adults. Incubation of compound heterozygous
embryos (expressing both mCherry and eGFP) in 10 mM of the prodrug
metronidazole (Met.; M3761, Sigma®) was carried out for 24–48 h. Controls
included c223 and c230 heterozygous siblings (eGFP positive, mCherryLinkage group Insertion position
Undetermined N/A
Zv6, 6:19.451 Mb Exon of a predicted novel gene
with Kelch-BTB/POZ domains;
same transcriptional orientation a
Zv6, 23:19.985 Mb Intron 1 of ikkγ a
Zv6, 5:39.948 Mb A) Intron of a predicted gene;
opposite transcriptional orientation
Zv6, 5:52.965 Mb B) Intron of a predicted gene;
opposite transcriptional orientation
Zv6, 5:38.323 Mb C) Intron of zgc:103557, homologous
to CDC42 effector protein 2; same
transcriptional orientation a
Undetermined N/A
Zv6, 9:10.198 Mb 0.7 kb 5′ to sequence homologous
to FEV and 18 kb 3′ to
betaA2-2-crystallin a
Undetermined N/A
l Undetermined N/A
s Undetermined N/A
Undetermined N/A
Zv6, 14:31.580 Mb 1.8 kb 5′ of ngn1 a
Zv6, 21:48.028 Mb 1.5 kb 3′ to sara2 a
Undetermined N/A
Undetermined N/A
Undetermined N/A
gy to published genomic sequence and further confirmed by PCR with primers
Fig. 2. Transient activation of UAS:mCherry in Gal4-VP16:UAS:eGFP transgenics. (A) Schematic of transient transactivation experiment. Tg(Gal4-VP16;UAS:
eGFP) embryos were injected with non-linearized UAS:mCherry plasmid and then screened for transient expression of mCherry. Because of the mosaic nature of
plasmid transmission, activation of UAS:mCherry is observed in a mosaic, tissue-specific pattern, entirely restricted to the field of eGFP expression. (B) eGFP
expression in skeletal muscle fibers of c218 embryo at 72 hpf. (C) Transient expression of mCherry is confined to eGFP-positive muscle fibers. (D) eGFP expression in
retina, midbrain, hindbrain and floorplate of c223 embryo. (E) Transient expression of mCherry in eGFP-positive neuroepithelium.
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examined by fluorescent microscopy before and after prodrug exposure. c223
larvae were fixed in 4% PFA overnight at 4 °C, and were sectioned (500 μm,
Vibrotome®). Following Hoechst nuclear staining, the pattern of mCherry
fluorescence was assessed with confocal microscopy. Widefield and confocal
sections were acquired using an Axiovert 200 M microscope coupled to the
Zeiss LSM 5 Pascal system.
Results
Generation of F1 founders displaying unique eGFP expression
patterns
We took a gene trap strategy to generate self reporting Gal4-
VP16 driver lines. The SAGVG construct is a Tol2-based
vector, designed to express Gal4-VP16 under the control of
endogenous regulatory elements in the zebrafish genome (Fig.
1A). The SAGVG construct was injected along with RNA
encoding transposase, and the resulting F0 fish were assayed for
transmission of eGFP expression patterns in their progeny. Over
half of the 49 incrossed F0 pairs (28/49) we examined produced
F1 Tg(Gal4-VP16;UAS:eGFP) progeny with restricted eGFP
expression. Ultimately, 15 stable lines were generated on the
basis of their discrete and reproducible patterns of eGFP
expression. Information on these lines and their allele designa-
tions is summarized in Table 1. Examples of tissue-specificpatterns of expression are depicted in Fig. 1. At the level of a
fluorescent stereomicroscope, the recovered lines exhibited
robust eGFP fluorescence in a variety of tissues, including
somitic muscle, notochord, pancreas, pineal, subregions of the
brain, the floor plate, spinal cord neurons, cranial musculature,
retina, lens, heart and heart valve (Fig. 1 and Supplementary
Movie 1). In some lines, eGFP was detected in only a small
subset of cells, such as in the presumptive pineal organ of c229
larvae (Figs. 1E, M), putative cranial ganglia (c215, c241; see
Supplementary Fig. 1) and a previously uncharacterized
population of ventral cells (c233; Fig. 1O).
Transactivation of UAS-regulated genes by Tg(Gal4-VP16;
UAS:eGFP)
The primary goal of this study was to develop methods to
generate a diverse collection of zebrafish Gal4-VP16 driver
lines for transcriptional activation of target genes of interest. To
validate whether reporter eGFP expression is Gal4-VP16-
dependent, we assessed transactivation using several UAS-
regulated elements, either transiently following injection of
plasmid DNA into Tg(Gal4-VP16;UAS:eGFP) embryos or in a
stable manner by mating transgenic fish to established UAS
lines. Two established driver lines were tested for their ability
to transactivate a UAS:mCherry red fluorescent reporter
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embryos. As demonstrated in Fig. 2, injection of UAS:mCherry
plasmid into c218 and c223 embryos resulted mCherry
expression in a few cells confined within the domain of
eGFP-expressing cells. This pattern of expression is produced
because of the mosaic inheritance of the plasmid in the cells of
the embryo following injection, and the requirement for Gal4-
VP16 transactivation for mCherry labeling. For example, in
c218 larvae, mCherry fluorescence was only observed within
eGFP-positive muscle fibers. The transient assays indicate that
Gal4-VP16 insertions can function in trans as tissue-specific
transcriptional activators.
The ability to transactivate expression in stable UAS lines
was evaluated by breeding Tg(Gal4-VP16;UAS:eGFP) fish to
Tg(UAS:Kaede) fish. In the Tg(UAS:Kaede) line, a gene
encoding the photoconvertible coral fluorescent protein Kaede
(Ando et al., 2002), has been placed under the regulation of
concatamerized UAS elements. When exposed to UV light,
Kaede is photoconverted and fluorescence irreversibly
changes from green to red, distinguishing it from cis-activated
eGFP. Thirteen out of fifteen putative driver lines mated with
Tg(UAS:Kaede), demonstrated robust transactivation (Fig. 3).
The two exceptions were c228 and c236, which failed to
show transactivation in the hindbrain or heart valve,
respectively (data not shown), despite highly localized eGFP
labeling.
Besides demonstrating transactivation in stable transgenic
lines, Tg(UAS:Kaede) fish can also be used in cell tracking
(Hatta et al., 2006). By photoconverting Kaede in a discrete
number of Gal4-VP16 expressing cells in the caudal tail of c233
larvae (6 dpf), we found that many migrated rostrally to reside
adjacent to the liver 2 days later (Fig. 4). Consistent with this
finding, fluorescence from eGFP labeling was only detected
within a cellular lining on the surface of the liver akin to
mesothelial cells in c233 adults (Fig. 4F). The result of cell
tracking using Tg(UAS:Kaede) fish indicates that the c233 line
expresses Gal4-VP16 in a highly mobile cell type in the
embryo, which most likely contributes to the mesothelial layer
of the liver.
Tg(Gal4-VP16;UAS:eGFP) lines for prodrug-dependent cell
ablation
The ability to ablate specific cells or a tissue of interest in a
temporally regulated manner allows the investigation of cell-cell
interactions and tissue regeneration. To facilitate these experi-
ments, we created a transgenic line (UAS:nfsB-mCherry) in which
the E. coli gene nfsB was placed under transcriptional control ofFig. 3. Tissue-specific transactivation of UAS:Kaede transgene. (A) Schematic of UAS
vector insertion site results in vector derived eGFP expression as well as transactivatio
UV light and by observing the emergence of red fluorescence in cells in which Gal4-V
were mated with a stable UAS:Kaede transgenic line. Resultant larvae were imaged fo
Kaede prior to UV exposure (shown in images B–I) and following exposure to UV l
Shown are photoconverted muscle fibers in c218 (B, B′), neurons and floor plate cell
notochord cells in c247 (F, F′), pinealocytes in c229 (G, G′), retinal cells in c220 (H
(ventral) and G (coronal). Images captured before and after UV exposure were digitUAS sequences. The nfsB gene encodes nitroreductase B (NTR),
which can convert prodrugs such as metronidazole (Met) into
toxic cellular metabolites (Drabek et al., 1997; Pisharath et al., in
press; Curado et al., in press). The NTR fusion protein
simultaneously renders cells visible due to mCherry fluorescence
and susceptible to prodrug treatment (Pisharath et al., in press;
Curado et al., in press).
To demonstrate the utility of this approach, c223 carriers were
mated to UAS:nfsB-mCherry transgenic fish. Compound hetero-
zygous larvae displayed colocalization of eGFP and mCherry
fluorescence in the expected tissue specific pattern. Larvae were
subjected to treatment with 10 mMMet for 24 h (from 56 to 80 h
post fertilization – hpf) and then imaged by confocal microscopy
to detect the presence of NTR-mCherry-expressing cells (Fig. 5).
When compared to untreated siblings, c223 larvae incubated in
prodrug for 24 h displayed a dramatic reduction in the number of
mCherry-positive cells in the floor plate (Fig. 5B). The few
remaining mCherry positive cells displayed nuclear fragmenta-
tion, an indicator of apoptosis (inset, Fig. 5C), suggesting that
ablation of the floor plate was complete. When c223 larvae
lacking the UAS:nfsB-mCherry transgene were treated with Met,
eGFP expression was unaffected (5D).
UAS:nfsB-mCherry transgenic fish were also mated to c230
carriers and resulting larvae were treated with Met from 30 to
54 hpf (Figs. 5H, I). Live imaging of the prodrug treated
compound heterozygotes, revealed abnormal morphology and
apoptotic mCherry positive cells in the notochord, which
eventually lead to a shortening of the body axis (Fig. 5M).
These defects were not observed in either untreated compound
heterozygotes (Figs. 5K, L), or Met-treated c230 siblings that
lacked the UAS:nfsB-mCherry transgene (Fig. 5J). Together the
analyses of c223 and c230 larvae demonstrate that tissue-
restricted cell death is both prodrug and UAS:nfsB-mCherry
transgene-dependent.
These results indicate that Gal4-VP16 driver lines can be
used to achieve prodrug-dependent, tissue-specific cell ablation
in UAS:nfsB-mCherry transgenic zebrafish.
Identifying and mapping insertions linked to eGFP expression
To gain insight into the regulation of Gal4-VP16 transcrip-
tion in recovered lines, we used LM-PCR to amplify and clone
the genomic sequences flanking vector insertions. Six lines,
shown to transactivate UAS-regulated gene expression, were
selected for evaluation. LM-PCR indicated multiple vector
insertions in all lines tested (from 3 to 10, data not shown). In all
but one line (c223), a single insertion was isolated that
segregated with eGFP expression. In c223, 3 insertions linked:Kaede transactivation experiment. Gal4-VP16 expression from a chromosomal
n of Kaede expression. Kaede expression is detected by exposure of embryos to
P16 is expressed. In these experiments Tg(Gal4-VP16;UAS:eGFP) F2 or F3 fish
r green fluorescent cells potentially resulting from expression of both eGFP and
ight (365 nm) for durations ranging from 30 to 60 sec (shown in images B′–I′).
s in c223 (C, C′), jaw musculature in c240 (D, D′), interneurons in c237 (E, E′),
, H′) and ventral migratory cells in c233 (I, I′). All are lateral views except D
ally processed in an identical manner. Scale bars=50 μm.
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lists the data from the insertions in the 6 lines examined;
including the chromosomal location and the identity of the
nearest known gene. Flanking genomic sequences are listed in
Supplementary Table 1.
As shown in Table 1, 8 insertions that segregated with eGFP
expression could be mapped to chromosomal loci, and three
mapped insertions possess the necessary transcriptional orienta-
tion within a gene to be potential gene traps. The c218 insertion
occurs in the terminal coding exon of a predicted gene that
encodes a protein with Kelch and BTB/POZ domains. The c223
insertion C maps to the first intron of a gene encoding a protein
with homology to Cdc42 effector protein 2. The c220 insertion
also maps to the first intron of a gene called inhibitor of kappa
light polypeptide gene enhancer in B-cells kinase gamma (ikkγ)
(Rothwarf et al., 1998), also known as NF-κB essential
modulator (NEMO) (Yamaoka et al., 1998). The c220 insertion
occurs in an intron upstream of the first coding exon of ikkγ and
is linked to a late onset phenotype causing abnormal body
curvature and lethality (Supplementary Fig. 2). Consistent with
a potentially mutagenic gene trapping event, a single transcript
was detected using RT-PCR with primers to Gal4 and ikkγ, and
following sequencing shown to be due to a fusion of the
upstream non-coding ikkγ exon spliced onto Gal4-VP16. This
result shows that the SAGVG construct can act as a genuine
gene trap construct.
The remaining mapped lines contain insertions that do not
predict conventional gene traps. Two of these lines had
insertions that mapped less than 20 kb from genes whose
endogenous expression is similar to the pattern of eGFP
expression associated with that particular line. The c237
insertion segregates with eGFP expression in presumptive
cranial ganglia, CNS neurons and in the retina. This insertion
resides 1.8 kb 5′ of neurogenin1, which is also expressed in
these tissues (Nechiporuk et al., 2005). The c229 allele, which
segregates with eGFP expression in pineal gland and lens, maps
to a position 18 kb 3′ of betaA2-2-crystallin (zgc:92722), a
gene which is highly represented in a cDNA library constructed
from zebrafish lens tissue (http://www.ncbi.nlm.nih.gov/Uni-
Gene/clust.cgi?ORG=Dr&CID=31370).
Discussion
The results described here confirm that Tol2 integrated Gal4-
VP16 transgenes not only self report via anUAS:eGFP cassette,
but can function as driver lines to activate UAS responder lines
in trans. The pilot screen has efficiently generated lines
displaying restricted eGFP expression in a wide variety ofFig. 4. Tracking of a migratory cell population by Kaede photoconversion. (A, A
Photoconverted red Kaede is restricted to the caudal tail. (B, B′) Same larvae at 8
magnification of same larva as (A) with presumptive liver showing green, but not
(E, E′, E″) Control transgenic larva that was not photoactivated shows only green,
fluorescent images were taken with the same exposure settings (40 s at low magnifica
(C–E) Scale bar=100 μm. (F) Cryostat section through the viscera of a c233 hetero
(arrow). Nuclei are blue due to Hoescht staining. (G) Hemotoxilin and eosin stain
Intestinal smooth muscle (arrowhead) and the coelomic space between the intestinetissues. The SAGVG vector is designed to take advantage of the
amplification inherent in the Gal4-VP16/UAS system (Koster
and Fraser, 2001) and is facilitated by recent advances in
transgenic methods (Kawakami et al., 2000). With Gal4-VP16
activation, detectable eGFP expression is expected even if
transcription levels from endogenous regulatory elements are
low. Ideally, this maximizes the number of driver lines that can
be obtained in a screen.
Most Gal4-VP16 driver lines maintained robust expres-
sion of eGFP over 3 generations. In some cases, such as
c218, we have observed a decrease in the frequency of
embryos/larvae expressing eGFP, in each new generation.
This occurrence could be due to transgene silencing, but as
SAGVG trapping events are self reporting, green fluores-
cence can be used to easily identify the progeny that have
escaped this phenomenon. Alternatively, as each line con-
tains several copies of SAGVG distributed throughout the
genome, random assortment could be reducing the copy
number of UAS:eGFP insertions available for Gal4 activation,
thereby affecting the amount of eGFP expressed. For some
lines, special efforts may be needed to maintain adequate
templates for transactivation.
To identify candidate genes associated with particular
expression patterns, and to gain insight into the mechanisms
underlying Gal4-VP16 expression, we determined the chromo-
somal localization of insertions responsible for eGFP expres-
sion patterns of interest. We examined 6 lines and found a total
of 8 insertions co-segregating with eGFP expression (c223 had
three linked insertions). Genuine gene trap events are
potentially mutagenic (Friedrich and Soriano, 1991). Although
the SAGVG construct was designed to function as a gene trap,
we found that only three insertions (c218, c220, c223-C) were
consistent with a gene trap mechanism (depicted in Fig. 6A and
B), on the basis of the identity and orientation of flanking
genomic sequences.
The c220 insertion is in the first intron of a known gene and
does indeed create a mutant fusion transcript, as demonstrated
by sequencing the RT-PCR product. When bred to homo-
zygosity, c220 fish display abnormal morphology and late
lethality (Supplementary Fig. 2). IKKγ mutations in humans
lead to a range of defects that include ectodermal dysplasia and
immunodeficiency (Smahi et al., 2000). The Ikkγ gene is X-
linked in mammals, and male mice hemizygous for a null Ikkγ
mutation die during mid-gestation. Although heterozygous
females are viable, likely due to random X inactivation of the
one wild-type copy of the gene they display ectodermal
dysplasia (Schmidt-Supprian et al., 2000). It is clear that
SAGVG can function as a bona fide gene trap vector with the′) Images of a 6 dpf c233 larva immediately after Kaede photoconversion.
dpf showing the red cells have migrated rostrally (arrow). (C, C′, C″) Higher
red cells. (D, D′, D″) At 8 dpf both green and red cells are observed (arrow).
around the liver at 8 dpf. All images are lateral views, anterior to the left. Red
tion, 12 s at higher magnification) and digitally processed in an identical manner.
zygous adult showing location of eGFP positive cells on the surface of the liver
ing of adjacent section to show histology and location of eGFP positive cells.
s and liver are indicated (*).
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whether the linked late phenotype seen in c220 fish is solely due
to the disruption in zebrafish ikkγ.
Two other lines (c229 and c237) appear to represent Gal4-
VP16-dependent enhancer traps (mechanism depicted in Fig.
6C), because the SAGVG insertions are located outside of
known transcribed regions. Activation of eGFP expression is
most likely mediated by Gal4-VP16, which in these lines is
capable of activating other UAS reporters in trans (see below).
Specific enhancer trap studies in the zebrafish have shown that
active insertions are often in close proximity to genes with
similar patterns of expression (Balciunas et al., 2004; Ellingsen
et al., 2005). In the case of c229 and c237, the SAGVG
construct has been inserted within 20 kb of genes with tissue-
specific expression predicted to be similar to the observed eGFP
labeling patterns. This suggests that nearby endogenous genes
and Gal4-VP16 are under the control of a common regulatory
enhancer(s). In these two cases, the site of transcription
initiation is unknown: it may be that there are cryptic promoter
sequences in upstream genomic DNA or within the vector itself.
Lines c228 and c236 are most likely examples of Gal4-VP16
independent eGFP expression (mechanism depicted in Fig. 6D).
Both insertions generate highly restricted eGFP expression, in
hindbrain rhombomeres (c228) or in the heart (c236),
respectively. However, when fish bearing either insertion were
bred to Tg(UAS:Kaede) fish, the resultant eGFP+ larvae failed
to show any evidence of Kaede photoconversion (see below).
This finding is consistent with an SAGVG insertion in which
transcription from the minimal promoter of eGFP is under the
direct influence of a local enhancer (Fig. 6D) rather than
mediated via Gal4-VP16 activation.
Although a somewhat unexpected finding, the multiple
mechanisms by which eGFP expression can be achieved from
the SAGVG construct likely accounts for the very high
frequency with which distinct expression patterns were
observed during the screening phase of this study. Fifty-seven
percent (28/49) of F0 paired crosses resulted in restricted
patterns of eGFP expression. We also demonstrated in this
report the utility of the SAGVG insertions to function as Gal4-
VP16 driver lines by transactivating 3 different UAS-regulated
genes to produce mCherry, Kaede and NTR-mCherry. Of the 15
lines assayed for transactivation, only 2 (c228 and c236) failed
to show labeling of other fluorescent proteins within eGFP-
expressing tissues. Significant resources will be required to
maintain a large panel of transactivating fish lines with
restricted patterns of eGFP expression generated from a moreFig. 5. Drug-dependent cell ablation following transactivation of nitroreductase exp
Gal4-VP16 transactivation of UAS:nfsB-mCherry transgene. Transgenic c223 larvae a
to 80 hpf (B–D) and 30 to 54 hpf (H–J), respectively. Negative, age-matched contro
Transactivation of the NTR-mCherry fusion protein in c223 in Z-stack projections
transverse vibratome sections of the neural tube (C and F), and in the c230 (H, K) n
fluorescent cells in the developing CNS (B, C) and notochord (H, I corresponding DIC
image, respectively). In B to G, nuclei are counterstained with Hoechst dye. Inset p
overlaying the notochord (asterisks). Arrows and arrowheads (C, D and F, G) mark
magnification inserts. Following prodrug treatment, the few remaining NTR-mChe
apoptotic (inset in F). (M)Morphology of c230 larvae at 54 hpf either treated with Met
that ablating notochord cells leads to reduced body length.extensive screen for Gal4-Vp16 insertions. Hence, it is
satisfying that Tol2 insertional events failing to lead to
transactivation are uncommon.
Spatially restricted photoconversion of Kaede can be used to
label individual cells, such as neurons (e.g., Figs. 3E, E′) and to
trace their axonal projections (Sato et al., 2006). This system is
also well suited to cell tracking (Hatta et al., 2006). Using this
technique we tracked an unknown population of photocon-
verted cells over time and demonstrated that they migrated
rostrally and came to lie in close proximity to the liver. Cell
position at 8 dpf strongly correlated with the tissue location of
eGFP positive cells in the mesothelium of the adult liver. Thus,
transactivation of Kaede by SAGVG transgenic lines and
subsequent photoconversion is a powerful method to monitor
the behavior of cells and their ultimate tissue specific fate.
In several experiments where Tg(UAS:Kaede) fish were bred
to Gal4-VP16 lines, we noted a mosaic pattern of transactiva-
tion. For instance larvae carrying the c237 allele possess
interneurons that fluoresce green. In some interneurons
photoconversion of Kaede was not observed (Fig. 3E′), even
though adjacent cells with similar morphology converted to red
fluorescence following exposure to UV light. This presumed
variegation in transactivation may represent differences in
chromatin state between otherwise similar cells. Such epige-
netic effects are known to cause variegation in transcription
levels and to be influenced by Gal4 activity (Ahmad and
Henikoff, 2001). Tissue variability in expression has also been
previously documented in Drosophila using the Gal4-VP16/
UAS system (Fischer et al., 1988) and may also influence
transactivation in zebrafish. Such potentially complicating
phenomena must be taken into account when interpreting
experiments where Gal4-VP16 drivers are used to misexpress
genes in given cell types and may necessitate fluorescently
tagging activated proteins of interest.
Two Gal4-VP16 lines were bred to fish transgenic for UAS:
nfsB-mCherry. The production of the NTR-mCherry fusion
protein led to prodrug-dependent cell ablation. Self-reporting
Gal4-VP16 drivers can be used for selective cell ablation in a
tissue-specific manner and for monitoring cell loss over time.
From our work and the work of others, it is clear that NTR
activity can be used to ablate a wide range of cell types
throughout the embryo/larva (Pisharath et al., in press; Curado
et al., in press). As more Gal4-VP16 driver lines become
available, the UAS:nfsB-mCherry transgenic line will constitute
an important resource in studying cellular regeneration and
cell–cell interactions.ressing transgene. (A) Schematic of NTR-mCherry fusion protein generated by
t 80 hpf (B–G) and c230 larvae at 54 hpf (H–M) were treated with Met from 56
ls had either one (E, F, K, L) or no copies (D, G, J) of the UAS:nfsB-mCherry.
of the trunk neural tube superimposed over bright field images (B and E) or in
otochord. Larvae expressing NTR-mCherry show a prodrug-dependent loss of
image) when compared to untreated controls (E, F and K, L corresponding DIC
anels show high magnification of the nuclei in cells of the ventral neural tube
individual fluorescent floor plate cells corresponding to identical cells in high
rry expressing floor plate cells possess fragmented nuclei indicative of being
(upper, as in H, I) or untreated (middle as in J, or lower as in K, L) demonstrating
Fig. 6. Potential mechanisms of eGFP expression. (A) Schematic representation of a target endogenous gene, with two exons (Roman numerals); E, endogenous
enhancer; P, endogenous promoter. (B) Insertion of SAGVG into the intron of gene, leading to activation of eGFP expression through traditional gene trap event;
SA, splice acceptor; UAS, Gal4-responsive upstream activating sequence; E1b, adenoviral E1b minimal promoter element. After splicing of Gal4-VP16 to
upstream endogenous coding sequence, the resulting fusion protein provides in cis activation of UAS:eGFP expression. (C and D) Two methods by which
enhancer trapping can lead to expression of eGFP expression (nb in reality both the orientation and distance from endogenous enhancer can be varied due to the
nature of enhancer activity). (C) Gal4-VP16-dependent activation of eGFP expression by enhancer trapping. Endogenous enhancer “E” drives Gal4-VP16
expression through interaction with cryptic promoter elements in either Tol2 vector or in genomic DNA adjacent to insertion. (D) Gal4-VP16-independent
activation of eGFP expression by enhancer trapping. Endogenous enhancer “E” drives eGFP expression directly through interaction with E1b minimal promoter
in UAS:eGFP cassette.
822 J.M. Davison et al. / Developmental Biology 304 (2007) 811–824Gal4-VP16 technology revolutionized experimental design
in Drosophila (Brand and Perrimon, 1993; Duffy, 2002) and we
envision the same advantages can be readily applied to
zebrafish. Future applications in the zebrafish could include
the rescue of mutations by expression of wild-type genes in
specific tissues (Zars et al., 2000a,b), the generation of cancer
models by expression of oncogenes in tissues of interest
(Folberg-Blum et al., 2002), dissection of signal transduction
pathways in specific cells by expression of dominant negative
(Elefant and Palter, 1999) or constitutively active pathway
components, and probing the neuronal basis of behavior (Brand
and Dormand, 1995). The binary nature of the Gal4-VP16
activation system will permit the production of many genetictools for zebrafish that cannot be generated as simple transgenic
lines due to lethality.
In conclusion, the current results demonstrate that distribu-
tion of SAGVG throughout the zebrafish genome by Tol2
transposition can generate a collection of effective Gal4-VP16
driver lines. Self-reporting transgenic lines are useful for
labeling cell types, and for transactivating other UAS-regulated
genes. Mapping has shown that there are apparently multiple
mechanisms by which transcription of Gal-VP16 can be
induced and may explain the efficient recovery of eGFP-
expressing lines. We anticipate that the widespread application
of this technology will provide an important new resource for
genetic manipulation in zebrafish.
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